anmelden
OMX Copenhagen 20
1.614,22
PKT
-3,08
PKT
-0,19
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.04.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 15.04.19 | A.P. Moeller - Maersk A-S (B) buy | Kepler Cheuvreux | |
| 12.04.19 | Novo Nordisk Outperform | Bernstein Research | |
| 11.04.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.04.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.04.19 | A.P. Moeller - Maersk A-S (B) buy | HSBC | |
| 20.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.03.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.03.19 | Novo Nordisk Outperform | Bernstein Research | |
| 05.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.03.19 | Novo Nordisk Reduce | HSBC | |
| 04.03.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.02.19 | Novo Nordisk Reduce | HSBC | |
| 05.02.19 | Novo Nordisk verkaufen | Barclays Capital | |
| 04.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.02.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 04.02.19 | Novo Nordisk Neutral | Credit Suisse Group | |
| 02.02.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 01.02.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 01.02.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 22.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.01.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 11.01.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 03.01.19 | Novo Nordisk Outperform | Bernstein Research | |
| 02.01.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.12.18 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 11.12.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 10.12.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 30.11.18 | Novo Nordisk buy | UBS AG | |
| 29.11.18 | Novo Nordisk neutral | Kepler Cheuvreux | |
| 26.11.18 | Novo Nordisk Reduce | HSBC | |
| 26.11.18 | Novo Nordisk buy | UBS AG | |
| 23.11.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 19.11.18 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.11.18 | Novo Nordisk Reduce | HSBC |
